Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 9.7.2019Mylan IRE Healthcare Limited (MYR)62565DUPHALAC (sir 1x500 ml (fľ.HDPE))12.7.2019R
 8.7.2019Haleon Czech Republic s.r.o. (HLE)23849Voltaren Rapid 25 mg (cps mol 20x25 mg (blis.PVC/PVDC/Al))18.7.2019R
 8.7.2019Upjohn EESV (UPO-NL)81425XALACOM (int opo 1x2,5 ml (fľ.+aplikátor))12.7.2019O
 8.7.2019Upjohn EESV (UPO-NL)58893XALATAN (int opo 1x2,5 ml (fľ.LDPE))9.7.2019O
 4.7.2019Zentiva, k.s. (ZNT-1)03688SUPPOSITORIA GLYCERINI LÉČIVA (sup 10x2,06 g (strip Al))8.7.2019R
 3.7.2019ratiopharm GmbH (RAT)57779Penbene 1,5 mil. IU (tbl flm 30x1,5 MU (blis.Al/PVC/PVDC))12.7.2019O
 3.7.2019Actavis Group PTC ehf. (ACT-5)4166BCodamol 500 mg/30 mg (tbl flm 30x500 mg/30 mg (blis.PVC/Al))1.11.2019Z
 3.7.2019Fresenius Kabi Austria GmbH (FRK-A)65317ELOTRACE (con inf 1x100 ml (fľ.inf.skl.))1.7.2019R
 3.7.2019N.V. Organon (ORG-NL)18600ELOCOM krém (crm der 1x30 g (tuba Al))3.7.2019O
 3.7.2019B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))2.7.2019R
 3.7.2019Merck Santé s.a.s (MES)42154GLUCOPHAGE XR (tbl plg 60x500 mg)3.7.2019R
 2.7.2019Pharmaselect International Beteiligungs GmbH (PML)08483Cyrdanax 20 mg/ ml (plv ifo 1x500 mg (liek.inj.skl.hnedá))2.7.2019R
 2.7.2019TS Pharma s.r.o. (TPH-1)37388Tarka 240 mg/4 mg tablety (tbl flm 56x240 mg/4 mg (blis.PVC/PVDC/Al))3.7.2019R
 2.7.2019Roche Registration GmbH (HLR-DE)06329Esbriet 267 mg tvrdé kapsuly (cps dur 252x1x267 mg (blis.PVC/PE/PCTFE/Al-jednotk.bal.))1.8.2019Z
 2.7.2019Novartis Europharm Limited (NEH-IE)2817BCosentyx 150 mg injekčný roztok v naplnenom pere (sol inj 2x1 ml/150 mg (striek.inj.skl. v pere SensoReady))1.7.2019O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)